These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 8889507)
1. p57K1P2 is expressed in Wilms' tumor with LOH of 11p15.5. Overall ML; Spencer J; Bakker M; Dziadek M; Smith PJ Genes Chromosomes Cancer; 1996 Sep; 17(1):56-9. PubMed ID: 8889507 [TBL] [Abstract][Full Text] [Related]
2. Cyclin-dependent kinase inhibitor p57KIP2 in soft tissue sarcomas and Wilms'tumors. Orlow I; Iavarone A; Crider-Miller SJ; Bonilla F; Latres E; Lee MH; Gerald WL; Massagué J; Weissman BE; Cordón-Cardó C Cancer Res; 1996 Mar; 56(6):1219-21. PubMed ID: 8640801 [TBL] [Abstract][Full Text] [Related]
3. Genomic imprinting of p57KIP2, a cyclin-dependent kinase inhibitor, in mouse. Hatada I; Mukai T Nat Genet; 1995 Oct; 11(2):204-6. PubMed ID: 7550351 [TBL] [Abstract][Full Text] [Related]
4. Comparative reverse transcription-polymerase chain reaction and in situ hybridization analyses of human imprinted p57KIP2 and insulin-like growth factor 2 gene transcripts in fetal kidney and Wilms' tumors using archival tissue. Soejima H; McLay J; Hatada I; Mukai T; Jinno Y; Niikawa N; Yun K Lab Invest; 1998 Jan; 78(1):19-28. PubMed ID: 9461119 [TBL] [Abstract][Full Text] [Related]
5. Selective maternal-allele loss in human lung cancers of the maternally expressed p57KIP2 gene at 11p15.5. Kondo M; Matsuoka S; Uchida K; Osada H; Nagatake M; Takagi K; Harper JW; Takahashi T; Elledge SJ; Takahashi T Oncogene; 1996 Mar; 12(6):1365-8. PubMed ID: 8649840 [TBL] [Abstract][Full Text] [Related]
6. Genomic organization of the human p57KIP2 gene and its analysis in the G401 Wilms' tumor assay. Reid LH; Crider-Miller SJ; West A; Lee MH; Massagué J; Weissman BE Cancer Res; 1996 Mar; 56(6):1214-8. PubMed ID: 8640800 [TBL] [Abstract][Full Text] [Related]
7. An imprinted gene p57KIP2 is mutated in Beckwith-Wiedemann syndrome. Hatada I; Ohashi H; Fukushima Y; Kaneko Y; Inoue M; Komoto Y; Okada A; Ohishi S; Nabetani A; Morisaki H; Nakayama M; Niikawa N; Mukai T Nat Genet; 1996 Oct; 14(2):171-3. PubMed ID: 8841187 [TBL] [Abstract][Full Text] [Related]
8. Human p57(KIP2) defines a new imprinted domain on chromosome 11p but is not a tumour suppressor gene in Wilms tumour. Taniguchi T; Okamoto K; Reeve AE Oncogene; 1997 Mar; 14(10):1201-6. PubMed ID: 9121769 [TBL] [Abstract][Full Text] [Related]
9. Loss of imprinting and genetic alterations of the cyclin-dependent kinase inhibitor p57KIP2 gene in head and neck squamous cell carcinoma. Lai S; Goepfert H; Gillenwater AM; Luna MA; El-Naggar AK Clin Cancer Res; 2000 Aug; 6(8):3172-6. PubMed ID: 10955800 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: a preliminary analysis. Grundy P; Telzerow P; Moksness J; Breslow NE Med Pediatr Oncol; 1996 Nov; 27(5):429-33. PubMed ID: 8926924 [TBL] [Abstract][Full Text] [Related]
11. Reduced expression of the cyclin-dependent kinase inhibitor gene p57KIP2 in Wilms' tumor. Thompson JS; Reese KJ; DeBaun MR; Perlman EJ; Feinberg AP Cancer Res; 1996 Dec; 56(24):5723-7. PubMed ID: 8971182 [TBL] [Abstract][Full Text] [Related]
12. Coding mutations in p57KIP2 are present in some cases of Beckwith-Wiedemann syndrome but are rare or absent in Wilms tumors. O'Keefe D; Dao D; Zhao L; Sanderson R; Warburton D; Weiss L; Anyane-Yeboa K; Tycko B Am J Hum Genet; 1997 Aug; 61(2):295-303. PubMed ID: 9311733 [TBL] [Abstract][Full Text] [Related]
13. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Ogawa O; Eccles MR; Szeto J; McNoe LA; Yun K; Maw MA; Smith PJ; Reeve AE Nature; 1993 Apr; 362(6422):749-51. PubMed ID: 8097018 [TBL] [Abstract][Full Text] [Related]
14. Genomic imprinting of human p57KIP2 and its reduced expression in Wilms' tumors. Hatada I; Inazawa J; Abe T; Nakayama M; Kaneko Y; Jinno Y; Niikawa N; Ohashi H; Fukushima Y; Iida K; Yutani C; Takahashi S; Chiba Y; Ohishi S; Mukai T Hum Mol Genet; 1996 Jun; 5(6):783-8. PubMed ID: 8776593 [TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity in Wilms' tumors, studied for six putative tumor suppressor regions, is limited to chromosome 11. Mannens M; Devilee P; Bliek J; Mandjes I; de Kraker J; Heyting C; Slater RM; Westerveld A Cancer Res; 1990 Jun; 50(11):3279-83. PubMed ID: 2159377 [TBL] [Abstract][Full Text] [Related]
18. Divergently transcribed overlapping genes expressed in liver and kidney and located in the 11p15.5 imprinted domain. Cooper PR; Smilinich NJ; Day CD; Nowak NJ; Reid LH; Pearsall RS; Reece M; Prawitt D; Landers J; Housman DE; Winterpacht A; Zabel BU; Pelletier J; Weissman BE; Shows TB; Higgins MJ Genomics; 1998 Apr; 49(1):38-51. PubMed ID: 9570947 [TBL] [Abstract][Full Text] [Related]
19. Chromosome 11p15.5 regional imprinting: comparative analysis of KIP2 and H19 in human tissues and Wilms' tumors. Chung WY; Yuan L; Feng L; Hensle T; Tycko B Hum Mol Genet; 1996 Aug; 5(8):1101-8. PubMed ID: 8842727 [TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of E-cadherin and cadherin-11 in Wilms' tumours. Schulz S; Becker KF; Braungart E; Reichmuth C; Klamt B; Becker I; Atkinson M; Gessler M; Höfler H J Pathol; 2000 Jun; 191(2):162-9. PubMed ID: 10861576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]